Related Experiment Videos
Palmitoylcarnitine modulates interaction protein kinase C delta-GAP-43
Joanna Sobiesiak-Mirska1, Katarzyna A Nałecz
1Nencki Institute of Experimental Biology, Polish Academy of Sciences, 02-093 Warsaw, Poland.
Biochemical and Biophysical Research Communications
|June 14, 2002
Summary
Palmitoylcarnitine influences protein kinase C (PKC) distribution and decreases phosphorylation of GAP-43 in neuroblastoma cells. This suggests palmitoylcarnitine may modulate neuronal signaling pathways.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Palmitoylcarnitine is known to promote neuronal differentiation.
- Protein kinase C (PKC) signaling is crucial for neuronal development.
- Growth cone-associated protein 43 (GAP-43) is a key substrate in neuronal plasticity.
Purpose of the Study:
- To investigate the effect of palmitoylcarnitine on PKC isoform distribution and interaction with GAP-43 in neuroblastoma cells.
- To determine how palmitoylcarnitine affects GAP-43 phosphorylation and its downstream signaling.
Main Methods:
- Utilized neuroblastoma NB-2a cells for experiments.
- Employed co-immunoprecipitation to study protein interactions.
- Analyzed subcellular distribution and phosphorylation levels of PKC isoforms and GAP-43.
Main Results:
- Palmitoylcarnitine altered the cytoplasmic distribution of high molecular weight PKCbeta and delta isoforms.
- It reduced GAP-43 association specifically with PKCdelta.
- Palmitoylcarnitine decreased GAP-43 phosphorylation without altering its subcellular localization.
Conclusions:
- Palmitoylcarnitine modulates PKC signaling pathways involved in neuronal differentiation.
- The observed effects on GAP-43 phosphorylation suggest a role in regulating calmodulin and G(0)-dependent signaling.
- These findings provide insights into the molecular mechanisms by which palmitoylcarnitine influences neuronal development.